-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Orchard Therapeutics plc quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2018 to Q3 2023.
- Orchard Therapeutics plc Income Tax Expense (Benefit) for the quarter ending September 30, 2023 was $976K.
- Orchard Therapeutics plc Income Tax Expense (Benefit) for the twelve months ending September 30, 2023 was -$140K, a 87.5% increase year-over-year.
- Orchard Therapeutics plc annual Income Tax Expense (Benefit) for 2022 was -$2.37M, a 387% decline from 2021.
- Orchard Therapeutics plc annual Income Tax Expense (Benefit) for 2021 was $828K.
- Orchard Therapeutics plc annual Income Tax Expense (Benefit) for 2020 was -$731K, a 67.4% increase from 2019.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)